Zobrazeno 1 - 10
of 160
pro vyhledávání: '"A. Zagrebneva"'
Autor:
A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 32-43 (2024)
The efficacy and safety of levilimab (LVL) in patients with active rheumatoid arthritis (RA) has been confirmed in controlled clinical trials. This article presents the results of a preliminary analysis of a non-interventional observational study of
Externí odkaz:
https://doaj.org/article/4031788a32de403ebea6e82d4f01065d
Autor:
E. L. Nasonov, V. N. Amirjanova, Y. A. Olyunin, Y. V. Muravyev, A. A. Baranov, E. V. Zonova, E. N. Otteva, A. I. Zagrebneva, D. I. Abdulganieva, P. I. Pchelnikova
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 4, Pp 435-449 (2023)
Rheumatoid arthritis (RA) is the most frequent immunoinflammatory (autoimmune) rheumatic disease characterized by chronic erosive arthritis and systemic damage to internal organs. The data obtained in the course of basic research on deciphering the m
Externí odkaz:
https://doaj.org/article/622d326a6fcc4ceba244273a93e899a0
Autor:
A. I. Zagrebneva, E. N. Simonova, T. V. Mezenova, N. B. Burmistrova, Yu. A. Gavrikova, E. O. Morozova, Zh. M. Kodzeva, K. S. Sapogina
Publikováno v:
Современная ревматология, Vol 16, Iss 6, Pp 73-79 (2022)
Objective: to confirm the efficacy and safety of levilimab in patients with rheumatoid arthritis (RA) switched from other interleukin 6 receptor inhibitors (iIL6R) for non-medical reasons.Patients and methods. A retrospective analysis of data from th
Externí odkaz:
https://doaj.org/article/3997aa7967654dbe93e600df9003064a
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract This paper is devoted to the synthesis of new signal processing algorithms based on the methodology of complete sufficient statistics and the possibility of using the Lehmann–Scheffe theorem. Using the example of a sequence of quasi-rectan
Externí odkaz:
https://doaj.org/article/c6420b0cceac4e51ae193a1029330a4a
Autor:
Ulyana A. Markina, Daria S. Fomina, Marina S. Lebedkina, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva, Zinaida Yu. Mutovina, Alexander V. Karaulov, Ekaterina I. Alexeeva, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 675-682 (2022)
Background. The use of virus-neutralizing monoclonal antibodies is an effective method of etiotropic therapy for SARS-CoV-2 in patients of high-risk groups of severe COVID-19. Regdanvimab is a single-component monoclonal antibodies immunoglobulin G1,
Externí odkaz:
https://doaj.org/article/1ca7266523cb42cb8962e01de2e8c208
Autor:
Alexey I. Khripun, Andrey V. Starshinin, Yulia O. Antipova, Mariana A. Lysenko, Yulia V. Urozhaeva, Olga F. Gavrilenko, Natalya A. Rusantsova, Andrei A. Tyazhelnikov, Elena Yu. Tikhonovskaya, Natalia V. Okolot, Maria V. Sokolova, Daria S. Fomina, Elena N. Simonova, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 668-674 (2022)
Aim. To study the effect of levilimab or baricitinib in combination with standard therapy (ST) on the incidence of severe viral pneumonia associated with a new coronavirus infection COVID-19. Materials and methods. A multicenter, open-label observ
Externí odkaz:
https://doaj.org/article/6e1e406685f6453fb14793c3ed915970
Autor:
Tatyana S. Kruglova, Darya S. Fomina, Nataliya G. Poteshkina, Nadija F. Frolova, Irina P. Beloglazova, Zinaida Yu. Mutovina, Inna V. Samsonova, Elena A. Kovalevskaja, Alena I. Zagrebneva, Sofya A. Serdotetckova, Anton A. Chernov, Maryana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 11, Pp 1316-1324 (2021)
Aim. To determine the criteria for the optimal use of IL-6 receptor blockers in patients with COVID-19 community-acquired pneumonia based on predictors of adverse outcomes. Materials and methods. The single-center, non-randomized prospective study
Externí odkaz:
https://doaj.org/article/6b1c4220c5664b0daa936e831f62deb9
Autor:
E. L. Nasonov, A. M. Lila, V. I. Mazurov, B. S. Belov, A. E. Karateev, T. V. Dubinina, O. A. Nikitinskaya, A. A. Baranov, D. I. Abdulganieva, S. V. Moiseev, A. I. Zagrebneva
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 3, Pp 239-254 (2021)
In mid-2021, the SARS-CoV-2 (Severe Acute Respiratory coronavirus 2) infection, which caused the coronavirus disease (COVID-19) pandemic, affected more than 157 million people in all regions of the world and led to more than 3.2 million deaths. It is
Externí odkaz:
https://doaj.org/article/b7f263ddf821441cb26b075f990e2ab7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
А. I. Zagrebneva, Е. А. Baryakh, Е. I. Zhelnova, N. G. Poteshkina, I. Р. Beloglazova, Z. Yu. Mutovina, I. V. Samsonova, Е. А. Kovalevskaya, V. V. Parshin, V. V. Pshenichnikova, D S. Fomina, Т. S. Kruglova, М. А. Lysenko, М. А. Dranitsyna
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 1-2, Pp 47-56 (2021)
The effects of baricitinib, a selective reversible inhibitor of Janus kinase 1 and 2, in the treatment of COVID-19 are associated with different aspects of pathogenesis — inhibition of viral endocytosis, reduction of excessive inflammatory respo
Externí odkaz:
https://doaj.org/article/8c61a3dab1a541eb8b65bcfed4de9455